Cyclic molecules as Bruton's tyrosine kinase inhibitor
US12384786B2 · kind B2 · utility
0Cited by
1References
11Claims
0Family size
Inventors
Key dates
| Filing date | Jan 16, 2020 |
| Grant date | Aug 12, 2025 |
| Priority date | — |
| Expiry date | Mar 31, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel molecule with protein tyrosine kinase inhibitory activity, and the synthesis and usage thereof. Specifically, the present invention relates to compound by formula A, pharmaceutically acceptable salts, hydrates or solvates thereof, and the synthesis and usage thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.